313 related articles for article (PubMed ID: 16928871)
21. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
22. NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling.
Sørensen CS; Melixetian M; Klein DK; Helin K
Cell Cycle; 2010 Feb; 9(3):450-5. PubMed ID: 20090422
[TBL] [Abstract][Full Text] [Related]
23. Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition.
Shimuta K; Nakajo N; Uto K; Hayano Y; Okazaki K; Sagata N
EMBO J; 2002 Jul; 21(14):3694-703. PubMed ID: 12110582
[TBL] [Abstract][Full Text] [Related]
24. Chk1 has an essential role in the survival of differentiated cortical neurons in the absence of DNA damage.
Ye W; Blain SW
Apoptosis; 2011 May; 16(5):449-59. PubMed ID: 21336968
[TBL] [Abstract][Full Text] [Related]
25. [Degradation of Cdc25A phosphatase in HeLa cells under normal and stress conditions].
Goloudina AR; Aksenov ND; Pospelov VA
Tsitologiia; 2004; 46(5):423-30. PubMed ID: 15344887
[TBL] [Abstract][Full Text] [Related]
26. The role of Cdc25A in the regulation of cell proliferation and apoptosis.
Shen T; Huang S
Anticancer Agents Med Chem; 2012 Jul; 12(6):631-9. PubMed ID: 22263797
[TBL] [Abstract][Full Text] [Related]
27. Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.
Morris EJ; Keramaris E; Rideout HJ; Slack RS; Dyson NJ; Stefanis L; Park DS
J Neurosci; 2001 Jul; 21(14):5017-26. PubMed ID: 11438577
[TBL] [Abstract][Full Text] [Related]
28. Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression.
Goto H; Natsume T; Kanemaki MT; Kaito A; Wang S; Gabazza EC; Inagaki M; Mizoguchi A
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30635443
[TBL] [Abstract][Full Text] [Related]
29. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
[TBL] [Abstract][Full Text] [Related]
30. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
[TBL] [Abstract][Full Text] [Related]
31. The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest.
Isoda M; Kanemori Y; Nakajo N; Uchida S; Yamashita K; Ueno H; Sagata N
Mol Biol Cell; 2009 Apr; 20(8):2186-95. PubMed ID: 19244340
[TBL] [Abstract][Full Text] [Related]
32. Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression.
Yin MB; Li ZR; Cao S; Durrani FA; Azrak RG; Frank C; Rustum YM
Mol Pharmacol; 2004 Jul; 66(1):153-60. PubMed ID: 15213307
[TBL] [Abstract][Full Text] [Related]
33. Rapid destruction of human Cdc25A in response to DNA damage.
Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint.
Goloudina A; Yamaguchi H; Chervyakova DB; Appella E; Fornace AJ; Bulavin DV
Cell Cycle; 2003; 2(5):473-8. PubMed ID: 12963847
[TBL] [Abstract][Full Text] [Related]
35. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
Fukasawa T; Enomoto A; Miyagawa K
Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
[TBL] [Abstract][Full Text] [Related]
36. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
37. Cyclin A-CDK1 suppresses the expression of the CDK1 activator CDC25A to safeguard timely mitotic entry.
Ng LY; Ma HT; Poon RYC
J Biol Chem; 2023 Mar; 299(3):102957. PubMed ID: 36717077
[TBL] [Abstract][Full Text] [Related]
38. CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage.
Schmitt E; Boutros R; Froment C; Monsarrat B; Ducommun B; Dozier C
J Cell Sci; 2006 Oct; 119(Pt 20):4269-75. PubMed ID: 17003105
[TBL] [Abstract][Full Text] [Related]
39. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.
Melixetian M; Klein DK; Sørensen CS; Helin K
Nat Cell Biol; 2009 Oct; 11(10):1247-53. PubMed ID: 19734889
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest.
Capasso H; Palermo C; Wan S; Rao H; John UP; O'Connell MJ; Walworth NC
J Cell Sci; 2002 Dec; 115(Pt 23):4555-64. PubMed ID: 12415000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
